Properties of solid dispersions of piroxicam in polyvinylpyrrolidone

被引:219
作者
Tantishaiyakul, V
Kaewnopparat, N
Ingkatawornwong, S
机构
[1] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem, Songkhla 90110, Thailand
[2] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Songkhla 90110, Thailand
关键词
piroxicam; solid dispersion; polyvinylpyrrolidone; Fourier transform infrared spectroscopy; X-ray diffraction; dissolution;
D O I
10.1016/S0378-5173(99)00070-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid dispersions of piroxicam were prepared with polyvinylpyrrolidone (PVP) K-17 PF and PVP K-90 by solvent method. The physical state and drug:PVP interaction of solid dispersions and physical mixtures were characterized by X-ray diffraction, Fourier transform infrared (FTIR) spectroscopy and differential scanning calorimetry (DSC). FTIR analysis demonstrated the presence of intermolecular hydrogen bonding between piroxicam and PVP in solid dispersions. These interactions reflected the changes in crystalline structures of piroxicam. The amorphousness within the PVP moeity might be predicted in piroxicam dispersions by the disappearance of N-H or O-H peak of piroxicam. Dissolution studies indicated a significant increase in dissolution of piroxicam when dispersed in PVP. The better results were obtained with the lower molecular weight PVP K-17 than with higher molecular weight PVP K-90. The non-amorphous solid dispersions in PVP K-17 showed almost equally fast dissolution rates to amorphous dispersions in PVP K-90. The mechanism of dissolution of solid dispersion in PVP K-90 is predominantly diffusion-controlled due to the very high viscosity of PVP K-90. Dissolution was maximum with the amorphous solid dispersions containing drug:PVP K-17 1:5 and 1:6 which showed a 40-fold increase in dissolution in 5 min as compared with pure drug. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 13 条
[1]  
*BASF, 1990, KOLL GRAD POL PHARM, P9
[2]   DISSOLUTION PROPERTIES OF NAPROXEN IN COMBINATIONS WITH POLYVINYLPYRROLIDONE [J].
BETTINETTI, G ;
MURA, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (08) :1353-1366
[3]  
FORD JL, 1986, PHARM ACTA HELV, V61, P69
[4]  
INEL PA, 1991, GOODMAN GILMANS PHAR, V1, P668
[5]   APPLICATION OF DIFFERENTIAL SCANNING CALORIMETRY TO THE STUDY OF SOLID DRUG DISPERSIONS [J].
KIM, KH ;
FRANK, MJ ;
HENDERSON, NL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (03) :283-289
[6]  
Mihalic M., 1986, ANAL PROFILES DRUG S, V15, P509
[7]   MECHANISM OF ADSORPTION OF CLINDAMYCIN AND TETRACYCLINE BY MONTMORILLONITE [J].
PORUBCAN, LS ;
SERNA, CJ ;
WHITE, JL ;
HEM, SL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (08) :1081-1087
[8]  
SEKIKAWA H, 1979, CHEM PHARM BULL, V27, P1223
[9]  
SEKIKAWA H, 1978, CHEM PHARM BULL, V26, P118
[10]   DISSOLUTION RATES OF HIGH-ENERGY SULFATHIAZOLE-POVIDONE COPRECIPITATES .2. CHARACTERIZATION OF FORM OF DRUG CONTROLLING ITS DISSOLUTION RATE VIA SOLUBILITY STUDIES [J].
SIMONELLI, AP ;
MEHTA, SC ;
HIGUCHI, WI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (03) :355-361